Đang chuẩn bị liên kết để tải về tài liệu:
Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

Hồng Ðiệp 59 10 pdf

Đang chuẩn bị nút TẢI XUỐNG, xin hãy chờ Tải xuống

Although the benefit of first-line epidermal growth factor receptor (EGFR) tyrosine-kinase inhibitors (TKIs) over chemotherapy has been demonstrated in several clinical trials, data from clinical practice is lacking and the optimal EGFR TKI to be used remains unclear. | Clinical management and outcome of patients with advanced NSCLC carrying EGFR mutations in Spain

TÀI LIỆU LIÊN QUAN

Ebook Neurological rehabilitation - Spasticity and contractures in clinical practice and research: Part 1

Ebook Child management in clinical dentistry: Part 2

Ebook Clinical management in psychodermatology: Part 1

Ebook Clinical management in psychodermatology: Part 2

Ebook Transfusion management of the obstetrical patient: A clinical casebook - Part 1

Clinical management of organophosphate poisoning in an Indian spectacled cobra (Naja naja; Linnaeus, 1758)

Ebook Child management in clinical dentistry: Part 1

Ebook Neurological rehabilitation - Spasticity and contractures in clinical practice and research: Part 2

Tests of clinical diagnostic: Part 2

Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation

Đã phát hiện trình chặn quảng cáo AdBlock

Trang web này phụ thuộc vào doanh thu từ số lần hiển thị quảng cáo để tồn tại. Vui lòng tắt trình chặn quảng cáo của bạn hoặc tạm dừng tính năng chặn quảng cáo cho trang web này.